Paul Tudor Jones Axsome Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 4,200 shares of AXSM stock, worth $552,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,200

Previous 40,866 89.72%

Holding current value

$552,720

Previous $4.77 Million 90.81%

% of portfolio

0.0%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$80.05 - $137.75 $3.27 Million - $5.63 Million	40,866 New	40,866 $4.77 Million
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $540,591 - $656,408	6,849 Added 36.08%	25,832 $2.32 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $1.25 Million - $1.53 Million	18,983 New	18,983 $1.53 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $376,919 - $583,028	6,453 Added 27.04%	30,321 $2.18 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $1.39 Million - $1.79 Million	23,868 New	23,868 $1.47 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $839,548 - $1.63 Million	-23,282 Reduced 53.08%	20,580 $918,000
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $741,442 - $1.59 Million	-34,105 Reduced 43.74%	43,862 $1.68 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $798,524 - $1.39 Million	33,693 Added 76.1%	77,967 $3.23 Million
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $1.41 Million - $2 Million	-46,055 Reduced 50.99%	44,274 $1.67 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $1.27 Million - $4.35 Million	63,668 Added 238.81%	90,329 $2.98 Million
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $843,850 - $1.23 Million	-16,667 Reduced 38.47%	26,661 $1.8 Million
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $2.18 Million - $3.17 Million	38,925 Added 884.06%	43,328 $2.45 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $595,331 - $776,776	-8,978 Reduced 67.1%	4,403 $359,000
Q3 2020 Nov 16, 2020	BUY	$68.34 - $85.84 $478,516 - $601,051	7,002 Added 109.77%	13,381 $953,000
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $318,120 - $629,543	6,379 New	6,379 $525,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $967,087 - $2.38 Million	-23,473 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $392,233 - $2.49 Million	23,473 New	23,473 $2.43 Million

Others Institutions Holding AXSM

# of Institutions

406

Shares Held

37.4M

Call Options Held

507K

Put Options Held

540K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.64B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account